Reliance Global Group, Inc. - Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by Reliance Global Group, Inc. on December 12, 2023. The filing details a series of material definitive agreements entered into with accredited investors to restructure existing warrant obligations and raise capital. The transactions involve the extension of warrant expiration dates, the exchange of warrants for common stock, and the inducement of warrant exercises at a reduced price.
Key Financial Metrics and Capital Structure
The filing does not provide standard financial performance metrics such as revenue, profit, cash flow, or operating margins. The primary financial data relates to capital transactions:
- Series F Warrant Exercise Proceeds: Approximately $1,381,474 in gross proceeds expected from the exercise of Series F Warrants.
- Exercise Price Adjustment: The exercise price for Series F Warrants was lowered to $0.6562 per share (Nasdaq Minimum Price).
- Shares Issued/To Be Issued:
- 300,000 shares of Common Stock issued via exchange of Series B Warrants.
- 2,105,264 shares of Common Stock to be issued upon exercise of Series F Warrants.
- 4,210,528 shares of Common Stock underlying new Series G Warrants (subject to shareholder approval).
Material Changes and Agreements
The Company executed four primary agreements on December 12, 2023:
- Extension of Series B Warrants: The expiration date for remaining Series B Warrants held by accredited investors was extended to December 28, 2028. In exchange, investors waived a restriction preventing the Company from conducting an "at-the-market" (ATM) offering of common stock after 60 days.
- Exchange of Series B Warrants: Accredited investors agreed to exchange remaining Series B Warrants (covering 300,000 shares) for 300,000 shares of Common Stock, to be issued within two trading days.
- Inducement to Exercise Series F Warrants: The Company lowered the exercise price of Series F Warrants to $0.6562 per share. Investors agreed to exercise warrants for 2,105,264 shares, generating approximately $1.38 million in proceeds. Closing is expected by December 15, 2023.
- Issuance of Series G Warrants: As consideration for the Series F inducement, the Company issued unregistered Series G Warrants to purchase 4,210,528 shares at the Nasdaq Minimum Price. These warrants are not exercisable until shareholder approval is obtained under Nasdaq Rule 5635(e).
Outlook, Risks, and Contingencies
Shareholder Approval Requirement: The Series G Warrants are contingent upon shareholder approval. The Company must hold a meeting within 90 days of the closing date to seek this approval. If not obtained, the Company must call a meeting every 90 days thereafter until approval is granted or the warrants expire.
Registration Obligations: The Company is required to file a Resale Registration Statement within 45 days of the closing date for the Series G Warrant shares and must use commercially reasonable efforts to have it declared effective within 90 days.
Issuance Restrictions: From December 12, 2023, until 60 days after the closing date, the Company is restricted from issuing or announcing the issuance of any Common Stock or equivalents, with customary carve-outs.
Price Adjustment Risk: If the Company issues Common Stock via an ATM offering at a cost basis lower than the Series G Warrant exercise price, the Series G exercise price will be adjusted downward to match the lower price.
Investor Verification Checklist
- Verify the closing date of the Series F Warrant exercise and the receipt of the $1,381,474 in proceeds.
- Confirm the issuance of the 300,000 Exchange Shares and the 2,105,264 Exercise Shares.
- Monitor the Company's announcement of the shareholder meeting to approve the Series G Warrants (required within 90 days of closing).
- Review the filing of the Resale Registration Statement for the Series G Warrant shares within 45 days of closing.
- Assess the potential dilution impact of the 4,210,528 Series G Warrant shares and the 60-day restriction on new issuances.